The 2015 Boom and Bust for Biotechs and Health Care
In yesterday’s big sell-session, Biotech and Health Care stocks were among the biggest laggards of the day.
Let’s take a look at the strong rally in 2015 that gave way to a bust or reversal recently.
We’ll start with the Biotech iShares ETF – IBB
A strong rally in July – continuing a strong uptrend through 2015 – occurred on reduced volume into $400 per share.
From there, price simply retraced to the rising 50 EMA – nothing unusual – and then broke impulsively under this level at the beginning of August on high sell volume.
When the market collapsed, Biotechs collapsed with it, falling from the $400 peak to spike-reverse off $300.
A logical and expected “ABC” Retracement pushed the ETF back into the underside of the falling 50 EMA at $360, but the trend took a turn for the worse when shares collapsed last week on increasing sell-volume.
At this point, we’re seeing an oversold rally develop off the $290.00 spike low and an upward pathway potentially opening up toward the $330.00 pivot again.
Nevertheless, focus your attention for the moment on $290.00 and $300.00 per share.
The situation is similar in Health Care (XLV):
Likewise, shares peaked in July on reduced bullish volume into $77.00 per share in the XLV ETF.
From there, all seemed well – except for the pick-up in sell-volume through August – until shares tumbled three fateful days in a row in August.
A mini-flash crash collapsed the price toward $57.00 for a brief moment ahead of a similar “ABC” Retracement toward the underside of the falling 50 EMA.
From there, shares began a renewed tumble lower on the highest volume bars of the year.
XLV shares are pivoting higher off the $64.00 level potentially toward $68.00 if we’re seeing another V-Spike Reversal.
Either way, note the current levels, the rapid transition from a strong to a weak trend, and the current volatility in these funds.
Follow along with members of the Afraid to Trade Premium Membership for real-time updates and additional trade planning.
Corey Rosenbloom, CMT
Afraid to Trade.com
Follow Corey on Twitter: http://twitter.com/afraidtotrade
Corey’s book The Complete Trading Course (Wiley Finance) is now available along with the newly released Profiting from the Life Cycle of a Stock Trend presentation (also from Wiley).
Trading in stocks can be pretty tough for novice traders, so that’s why we are required to be extremely careful in how we work out things. I love doing Forex trading that too with OctaFX broker where I get ideal conditions which includes low spread of 0.2 pips, high leverage up to 1.500 plus there is low stop out level at just 15%, so that’s seriously helpful and allows me to be successful while there is also 24/5 support service available to work with.